How To Be Successful In The Attention Deficit Hyperactivity Disorder Drugs Market Industry.

The global attention deficit hyperactivity disorder (ADHD) drugs market is expected to post a CAGR of close to 6% during the period 2019-2023, according to the latest market research report by Technavio.

With the growing prevalence of attention deficit hyperactivity disorder across the world, the ADHD market is witnessing an increase in the number of government initiatives to promote the awareness of the disease and to fund drug development in the area mental health therapeutics. For instance, in 2016, the US Department of Health and Human Services (HHS) donated USD 3,454 million to the Substance Abuse and Mental Health Services Administration (SAMHSA) to address the needs of people with mental illnesses. Such rising government support to help people with ADHD will drive market growth during the forecast period.

Download the free sample report @ http://bit.ly/34wsF5r

As per Technavio, the reformulation of marketed drugs will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global attention deficit hyperactivity disorder drugs market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.

Global attention deficit hyperactivity disorder (ADHD) drugs market: Reformulation of Marketed Drugs

Earlier, the ADHD market was dominated by immediate-release tablets for oral use. However, the short duration of action of these drugs necessitates multiple dosing, thereby decreasing patient compliance. Thus, to combat this situation, vendors in the market are increasingly focusing on the reformulation of various marketed drugs. The reformulation of marketed drugs provides an opportunity to grab patent term extensions, which can delay the entry of generic versions in the market. The reformulation of drugs also helps in reducing the dosage frequency, thereby increasing patient compliance.

“Apart from the reformulation of marketed drugs, several other factors such as the rising incidence rate of ADHD among children, growing off-label use of ADHD medications among children, and the increase in M&A will have a significant impact on the growth of the ADHD drugs market during the forecast period,” says a senior research analyst at Technavio.

Get the Complete Report @ http://bit.ly/2qosNFe